Reliability and validity of the repeatable battery for assessment of neuropsychological status scale in maintenance hemodialysis patients

doi:10.3969/j.issn.1006-7795.2025.05.017

Abstract

Abstract: Objective To evaluate the reliability and validity of the Chinese version of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with maintenance hemodialysis (MHD). Methods The general information and medical history of 84 MHD patients were collected, and the Mini-Mental State Exam (MMSE), Montreal Cognitive Assessment Scale (MoCA), and RBANS were conducted. The reliability of the scale was assessed by Cronbach α and split-half reliability. The structure and convergent validity of the scale were assessed by confirmatory factor analysis, and the RBANS scores’ correlation to MoCA and MMSE scores was analyzed by Spearman correlation analysis. The predictive value of the RBANS total score on cognitive impairment (CI) was analyzed by receiver operating characteristic (ROC) curve. ' The Cronbach's alpha coefficient of the RBANS total scale was 0.896, split-half reliability was 0.911， and reliability for the five dimensions of the RBANS ranged from 0.618 to 0.791. Confirmatory factor analysis indicated that the overall fit of the five-dimensional model of the RBANS scale was acceptable (χ²/df =1.587, root mean square error of approximation=0.084, comparative fit index=0.967, incremental fit index=0. 968, Tucker-Lewis index=0.947, goodness of fit index= 0.891). The average variance extracted (AVE) for the five dimensions of the RBANS ranged from 0.525 to 0.863, while the composite reliability (CR) ranged from 0.733 to 0.926, indicating good convergent validity of the scale. Furthermore, Spearman correlation analysis revealed that the total RBANS score was negatively correlated to the age of MHD patients and positively correlated to years of education, as well as the total scores of MMSE and MoCA (all P<0.01). The ROC curve analysis indicated that the area under the curve (AUC) for the total RBANS score in predicting CI was 0.891 (P<0.01), suggesting a high predictive value. Conclusion The Chinese version of RBANS has good reliability and validity in MHD patients, and can be used as a measure of cognitive function in MHD patients.

Key words: neuropsychological assessment, cognitive impairment, maintenance hemodialysis, reliability, validity, Repeatable Battery for the Assessment of Neuropsychological Status

CLC Number:

R692

Wang Xiaoqi, Liu Conghui, Shao Feng, Zhou Jingjing, Yang Fan, Li Zhongxin. Reliability and validity of the repeatable battery for assessment of neuropsychological status scale in maintenance hemodialysis patients[J]. Journal of Capital Medical University, 2025, 46(5): 877-884.

References

［1］薛广团, 舒亮辉, 高巍. 维持性血液透析患者认知功能障碍与中医证型特征的相关性［J］. 实用临床医药杂志, 2021, 25 (22): 55-58.
［2］ Drew D A, Tighiouart H, Rollins J, et al. Evaluation of screening tests for cognitive impairment in patients receiving maintenance hemodialysis［J］. J Am Soc Nephrol, 2020, 31(4): 855-864.
［3］ O'Lone E, Connors M, Masson P, et al. Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis［J］. Am J Kidney Dis, 2016, 67(6): 925-935.
［4］ Angermann S, Schier J, Baumann M, et al. Cognitive impairment is associated with mortality in hemodialysis patients［J］. J Alzheimers Dis, 2018, 66(4): 1529-1537.
［5］ Randolph C, Tierney M C, Mohr E, et al. The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity［J］. J Clin Exp Neuropsychol, 1998, 20(3): 310-319.
［6］ Raudeberg R, Karr J E, Iverson G L, et al. Examining the repeatable battery for the assessment of neuropsychological status validity indices in people with schizophrenia spectrum disorders［J］. Clin Neuropsychol, 2023, 37(1): 101－118.
［7］ Dyer A H, Briggs R, Laird E, et al. Glycated haemoglobin (HbA1c ), diabetes and neuropsychological performance in community-dwelling older adults［J］. Diabet Med, 2021, 38(11): e14668.
［8］ Zhang C Y, Deng Y M, Li D M, et al. Reliability and validity of the repeatable battery for assessment of neuropsychological status scale in evaluation of vascular cognitive impairment in elderly Han population［J］. Noro Psikiyatr Ars, 2022, 59(2): 147－150.
［9］ Cheng Y, Wu W Y, Wang J Q, et al. Reliability and validity of the repeatable battery for the assessment of neuropsychological status in community-dwelling elderly［J］. Arch Med Sci, 2011, 7(5): 850-857.
［10］ Suraweera C, Anandakumar D, Dahanayake D, et al. Validation of the Sinhala version of the repeatable battery for assessment of neuropsychological status (RBANS)［J］. Ceylon Med J, 2016, 61(4): 167－170.
［11］ Tsatali M, Fotiadou F, Giaglis G, et al. The repeatable battery for the assessment of the neuropsychological status (RBANS): a diagnostic validity study in Greek elderly［J］. Aging Clin Exp Res, 2019, 31(9): 1305－1312.
［12］ Hobart M P, Goldberg R, Bartko J J, et al. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons［J］. Am J Psychiatry, 1999, 156(12): 1951－1957.
［13］ Bentler P M. Comparative fit indexes in structural models［J］. Psychol Bull, 1990, 107(2): 238-246.
［14］ Browne M W, Cudeck R. Alternative ways of assessing model fit［J］. Sociol Methods Res, 1992, 21(2): 230-258.
［15］ Hair J F. Multivariate data analysis［M］. 7th ed. London: Pearson, 2014: 604-605.
［16］ Ciesielska N, Sokołowski R, Mazur E, et al. Is the Montreal cognitive assessment (MoCA) test better suited than the mini-mental state examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis［J］. Psychiatr Pol, 2016, 50(5): 1039－1052.
［17］ Dong Y H, Sharma V K, Chan B P L, et al. The montreal cognitive assessment (MoCA) is superior to the mini-mental state examination (MMSE) for the detection of vascular cognitive impairment after acute stroke［J］. J Neurol Sci, 2010, 299(1/2): 15－18.
［18］ Jia X F, Wang Z H, Huang F F, et al. A comparison of the mini-mental state examination (MMSE) with the Montreal cognitive assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study［J］. BMC Psychiatry, 2021, 21(1): 485.
［19］杨贵刚, 田菊, 谭云龙, 等. 重复性成套神经心理状态测验在北京地区正常人群中的应用［J］. 中国心理卫生杂志, 2010, 24(12): 926-931.［20］ Karakizlis H, Thiele S, Greene B, et al. Cognitive performance in dialysis patients-“when is the right time to test?”［J］. BMC Nephrol, 2021, 22(1): 205.
［21］ Gold J M, Queern C, Iannone V N, et al. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity［J］. Am J Psychiatry, 1999, 156(12): 1944－1950.
［22］ Beath N, Asmal L, Van Den Heuvel L, et al. Validation of the Montreal cognitive assessment against the RBANS in a healthy South African cohort［J］. S Afr J Psychiatr, 2018, 24: 1304.